Systemic Inflammatory Attenuation is the therapeutic or physiological process of reducing the chronic, low-grade inflammatory state that pervades the entire organism and is a major driver of age-related disease. This attenuation involves the down-regulation of pro-inflammatory cytokines and the restoration of a balanced immune response. Successful attenuation is a key strategy for promoting healthspan and longevity.
Origin
This term is a core concept in immunometabolism and gerontology, combining the broad scope of ‘systemic’ inflammation with the action of ‘attenuation,’ which means to reduce the force or effect. The understanding of chronic low-grade inflammation, or “inflammaging,” has led to clinical strategies focused on modulating this underlying process rather than merely treating symptoms. Hormones play a significant role in this modulation.
Mechanism
The mechanism is complex, involving the modulation of nuclear factor kappa B (NF-κB) signaling, a central regulator of inflammatory gene expression. Hormones such as cortisol, dehydroepiandrosterone (DHEA), and specific sex steroids possess anti-inflammatory properties, influencing immune cell differentiation and cytokine production. Attenuation also involves promoting gut barrier integrity and optimizing the balance of omega fatty acids to shift the eicosanoid profile toward a less inflammatory state.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.